Oct. 6, 2024 (Sun. Only)
2024 Nuclear Pharmacy Conference
(6 hrs. CPE)

Oct. 6, 2024 (Sun. Only)
2024 Nuclear Pharmacy Conference
(6 hrs. CPE)

$175.00

ACCREDITATION

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an ACPE knowledge-based activity. Participants may receive up to 6 hours of CPE credit by attending sessions and successfully completing the CPE activity evaluation.

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

 

DISCLOSURES

Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity

TARGET AUDIENCE
Nuclear Pharmacists and Technicians or any pharmacist and technician interested in nuclear pharmacy education.

CANCELLATION POLICY
Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

ZOOM WEBINAR INFORMATION
Participants may join via any electronic device. Be sure to have downloaded the ZOOM software in advance to avoid any delays. You will be able to see the speakers and their presentations. You will be able to respond to speaker learning assessments via the CHAT Feature and ask questions via the Q&A Feature.

 

Required Computer Hardware/Software

Please ensure your computer system meets the following minimum requirements:

Zoom system requirements: Virtual Desktop Infrastructure (VDI)

  • Broadband internet connection: cable, high-speed DSL and any other medium that is internet accessible
  • Internet Browser (MAC and/or Windows) – Internet Explorer, Google Chrome, Firefox, Safari
  • Media Requirements – Microsoft PowerPoint, Adobe reader

 

 

 

 

 

 

Category: Tag:

Description

NUCLEAR PHARMACY CONFERENCE

Sunday, October 6, 2024

Advancements in Pulmonary Imaging – It’s Here – Exploring Technegas

8:00am-9:30am

Vesper Grantham, MEd, RT(N), CNMT, Chair, Medical Imaging and Radiation Sciences, Program Director, Nuclear Medicine

Upon completion of this activity, participants will be able to: Describe the protocol features of Technegas including equipment, radiopharmaceutical administration, and imaging protocol; Discuss the advantages of Technegas over traditional ventilation imaging agents; Evaluate implementation of Technegas for nuclear medicine departments.

UAN: 0675-0000-24-035-L01-P

 

The U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Use of Isotopes (ACMUI)   

9:30am - 11:00am                                                

Richard Green, BSPharm, RPh, BCNP FAPhA,

Upon completion of this activity, participants will be able to: Discuss the ACMUI role in the NRC; Describe the current make-up of the ACMUI membership; Discuss the topics recently taken up by the ACMUI; Identify areas of future NRC action as a result of ACMUI reports.

UAN: 0675-0000-24-036-L03-P

 

Radiotherapeutics: Best Practice and Updates                                               

11:15am-12:45pm

Akram Hussein, PharmD, MBA, BCNP, Director – Nuclear Medicine Radiopharmacy, MD Anderson Cancer Center

Upon completion of this activity, participants will be able to: Describe the tools and infrastructure needed for a successful radiotherapeutics program; Discuss how a commercial and hospital nuclear pharmacist can support a theranostics center; Explain medical events related to radiotherapies and how to decrease their occurrence.

UAN: 0675-0000-24-037-L01-P

 

Instrument Review and Best Practices for Nuclear Pharmacy                        

12:45pm-2:15pm          

Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility

Upon completion of this activity, participants will be able to: Describe National Institute of Standards and Technology primary and secondary sources; Explain the error rate in measuring activity from various radiopharmaceuticals; Describe how to change or add a new calibration setting on the dose calibrators.

UAN: 0675-0000-24-038-L01-P

 

***  SCHEDULE SUBJECT TO CHANGE